Effect of Psychotherapy on Quality of Life and Recurrence of Events in Patients With Recurrent Vasovagal Syncope: A Randomized Pilot Study

Sponsor
Mauricio Ibrahim Scanavacca (Other)
Overall Status
Completed
CT.gov ID
NCT04252729
Collaborator
(none)
10
1
2
12.9
0.8

Study Details

Study Description

Brief Summary

Recurrent vasovagal syncope although presenting a benign prognosis in terms of survival, is associated with significant impairment of quality of life. The impaired emotional status is also related to the recurrence of the events, closing a negative cycle for the evolution of the disease. This study aims to evaluate the effect of psychotherapy on the quality of life and in the number of syncope and pre-syncope events during one year of follow-up of patients with recurrent vasovagal syncope.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Psychotherapy
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
10 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Effect of Psychotherapy on Quality of Life and Recurrence of Events in Patients With Recurrent Vasovagal Syncope: A Randomized Pilot Study
Actual Study Start Date :
Jul 27, 2017
Actual Primary Completion Date :
Aug 3, 2018
Actual Study Completion Date :
Aug 23, 2018

Arms and Interventions

Arm Intervention/Treatment
Experimental: Psychotherapy

Psychotherapy sessions based on the theoretical line of Psychoanalytic Psychosomatics for 1 year, every 10 days.

Procedure: Psychotherapy
Psychotherapy sessions based on Psychoanalytic Psychosomatics

No Intervention: No psychotherapy

Follow-up according to institutional routine, without psychotherapy sessions.

Outcome Measures

Primary Outcome Measures

  1. Quality of life analysis performed by the Short Form 36 Instrument [1 week]

    Data collected at first visit

  2. Quality of life analysis performed by the Short Form 36 Instrument [6 months]

    Data collected at first visit, 6 and 12 months (global assessment and by specific domains).

  3. Quality of life analysis performed by the Short Form 36 Instrument [12 months]

    Data collected at 12 months (global assessment and by specific domains).

Secondary Outcome Measures

  1. Demographic data [12 months]

    Gender, age, date of birth, race, monthly income and education level.

  2. Number of comorbidities [12 months]

    Especially use of alcohol, drugs and smoking

  3. Use of concomitant medication [12 months]

    Prescription medication that the participant uses.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Diagnosis of vasovagal syncope with positive TILT TEST and recurrent episodes (≥2 episode within 6 months)

  • Signed Free and Informed Consent Form

Exclusion Criteria:
  • Severe comorbidity with life expectancy <1 year

  • Age <18 years

  • Current psychotherapeutic follow-up

  • Cardiac or neurological syncope

  • Pregnancy

Contacts and Locations

Locations

Site City State Country Postal Code
1 Instituto do Coração - Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo Sao Paulo SP Brazil 05403010

Sponsors and Collaborators

  • Mauricio Ibrahim Scanavacca

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Mauricio Ibrahim Scanavacca, Arrhythmia Clinical Unit Director, University of Sao Paulo General Hospital
ClinicalTrials.gov Identifier:
NCT04252729
Other Study ID Numbers:
  • 4383/16/049
First Posted:
Feb 5, 2020
Last Update Posted:
Feb 5, 2020
Last Verified:
Jan 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Mauricio Ibrahim Scanavacca, Arrhythmia Clinical Unit Director, University of Sao Paulo General Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 5, 2020